Outsourcing Oversight: FDA Form 483
Learn why maintaining rigorous third-party quality management is just as vital to your drug pipeline as the science itself. Read about why the critical operational risks highlighted in the FDA Form 483 Warning Letter are important to be aware of, and what dangerous oversight gaps exist in pharmaceutical outsourcing.
GLP and GCP: How the FDA and EPA Watch Over Science
Two of the most important sets of rules are called GLP and GCP. In 2026, the two main government agencies responsible for these rules, the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA), are working together more than ever before. Re: FDA & EPA Oversight.
